Kathryn Hassell, MD

Dr. Hassell provides inpatient and outpatient care to adults with sickle cell disease at the University of Colorado Hospital. She is a site principal investigator for multi-center clinical trials for adults with sickle cell disease, and has provided national leadership on study steering and executive committees. Dr. Hassell has led several regional projects through the Mountain States Genetics Regional Collaborative Center, and serves on the Newborn Screening Advisory Committee for the Colorado State Department of Health. She also sits on the steering committees of a number of national projects including the Sickle Cell Disease Treatment Demonstration Project for HRSA, the American Society of Hematology’s Public Health Taskforce, and the Registries and Surveillance for Hemoglobinopathies (RuSH) Project for the CDC and NIH.

Representative Publications:

Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠

AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain

Quality of care in sickle cell disease: Cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care

Effects of hydroxyurea treatment for patients with hemoglobin SC disease

The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease

Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity